How to access Omvoh from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Emirati patient with moderately-to-severely active ulcerative colitis, or moderately-to-severely active Crohn's disease, who has had an inadequate response to prior therapy may receive a prescription for Omvoh (mirikizumab) from their treating gastroenterologist. Omvoh is FDA-approved in the United States and manufactured by Eli Lilly. It is a humanised IgG4 monoclonal antibody that selectively targets the p19 subunit of interleukin-23, and was the first IL-23p19-selective antibody FDA-approved specifically for ulcerative colitis. Access through the UAE hospital pharmacies varies by institution; when the specific presentation needed is not locally stocked, a named-patient import route remains legitimate for the patient whose gastroenterologist has already prescribed the drug.
This guide explains the pathway, what documentation your physician needs, typical costs and timing, and where Reserve Meds fits in.
Ask about Omvoh in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Omvoh is an injectable anti-IL-23p19 monoclonal antibody. For ulcerative colitis, the induction regimen is 300 mg intravenously at weeks 0, 4, and 8, followed by subcutaneous maintenance at 200 mg every 4 weeks. The Crohn's disease regimen follows a similar induction-then-maintenance structure per FDA labeling. The IL-23 class has a cleaner safety profile than the JAK class and does not carry an FDA boxed warning. Pre-treatment screening per FDA labeling includes tuberculosis evaluation, hepatitis B and C serology, and review of vaccination status; live vaccines are not recommended during therapy. Your gastroenterologist will document severity (Mayo score, endoscopic findings, prior therapy exposure) and the induction and maintenance plan before starting Omvoh.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Omvoh legally importable into the UAE?
Yes, through the UAE Ministry of Health and Prevention (MoHAP) named-patient / personal-use import framework, coordinated with the dispensing hospital pharmacy. The UAE has a mature named-patient mechanism that has supported specialty IBD, immunology, and rare-disease access for many years.
The MoHAP named-patient route allows an Emirati-licensed physician to request import of a medicine when: (a) the medicine has been approved by a recognised reference authority (FDA qualifies), (b) no clinically equivalent locally available alternative is suitable for the patient, (c) the treating physician takes clinical responsibility for use, and (d) chain of custody is documented from the US source to the administering pharmacy. Applications are reviewed by the MoHAP Drug Sector.
How the pathway works, step by step
- Consultation with your treating gastroenterologist. The prescribing decision is clinical. Your gastroenterologist documents the indication (UC or Crohn's), severity scoring, prior therapy history, and rationale for Omvoh.
- Baseline screening. TB, viral hepatitis, and vaccination review are completed and documented per FDA labeling.
- MoHAP named-patient application. Your gastroenterologist or hospital pharmacy files the application with clinical rationale, patient reference, presentation (IV induction or SC maintenance), quantity, and chain-of-custody plan.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure product from Eli Lilly's authorised distribution under DSCSA chain-of-custody.
- Cold-chain shipment. Omvoh is a biologic requiring refrigerated transport (2 to 8 degrees Celsius) with temperature-excursion monitoring end to end.
- Arrival and first administration. The dispensing facility releases product against the physician's prescription. IV induction is administered at the hospital or infusion centre; SC maintenance follows on the planned schedule.
What documentation your physician needs
Your physician will typically need to provide:
- A clinical rationale letter confirming the IBD diagnosis (UC or Crohn's), severity scoring, prior therapy history (including any biologic or JAK exposure), and Omvoh as the indicated treatment
- Verification of their UAE medical licence (SCFHS / MOH)
- A patient identifier (anonymised reference preferred)
- Documented pre-treatment screening (TB, hepatitis) and vaccination review
- The planned induction schedule (IV) and maintenance schedule (SC) with presentation details
- Identification of the infusion facility for IV induction
Reserve Meds provides a physician documentation kit that bundles the templates MoHAP reviewers expect for IL-23 biologic imports with an IV induction plus SC maintenance structure, including cold-chain handling.
Typical costs and indicative timing
Reserve Meds gives you a transparent, itemised custom quote at intake. Medicine price: quote on request. You get a written quote for your case before you commit. International cold-chain logistics, MoHAP documentation handling, and coordination add incremental cost. The delivered quote we issue at intake itemises each line so nothing is hidden.
We give you a written timeline estimate for your case before you commit. Maintenance doses are scheduled against the physician's cadence.
; A brief culturally-aware note: Ramadan and Hajj seasons affect scheduling across the UAE tertiary centres, and our team coordinates against your family's calendar.
Where Reserve Meds fits in
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Omvoh specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody from manufacturer to export.
- Documentation. Regulatory package tailored for your gastroenterologist and for MoHAP review.
- Cold-chain logistics. Temperature-controlled, internationally tracked shipment with excursion monitoring.
- Dedicated case lead. A named point of contact for your family and your gastroenterologist across the full case arc.
We are a coordinator, not the prescriber, not the dispensing pharmacy. All clinical decisions remain with your treating gastroenterologist, and dispensing and administration sit with the licensed UAE facility of record.
FAQ
Is this legal in the UAE?
Yes, when executed through the MoHAP named-patient / personal-use framework with appropriate documentation, clinical rationale, and a licensed dispensing and administering facility.
How does Omvoh compare to Skyrizi for IBD?
Skyrizi and Omvoh are both IL-23p19-selective monoclonal antibodies with FDA approvals spanning IBD indications, but they differ in dosing cadence, trial evidence, and label specifics. Your gastroenterologist chooses based on indication, prior therapy, and response expectations.
Why does UC induction use IV while maintenance uses SC?
The induction regimen relies on higher systemic exposure early in therapy; the SC maintenance dose then sustains response. Your gastroenterologist will coordinate induction at an infusion-capable facility and transition to SC dosing per labeling.
What if my gastroenterologist has not done a named-patient request before?
The process is institutional and your IBD service will have encountered it. Our documentation kit is written for first-time applicants.
Will private insurance cover this?
Cash-pay is the default posture. Some UAE private insurers reimburse named-patient imports on a case-by-case basis; we supply documentation but do not process insurance claims directly.
Next step
For Omvoh coordination in the UAE, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
This guide is educational, not medical advice. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not the prescriber and not the dispensing pharmacy. All clinical decisions remain with the treating physician.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.